AUG 07, 2018
CMS Announces Plan to Introduce Drug Step Therapy in Medicare Advantage
We believe this is bad for ophthalmology and for patients; such a legally dubious policy would limit physicians’ and patients’ treatment choices for more than a third of Medicare patients